Marie L. Schmidt
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Accelerated qualification of diagnostic tests during an ongoing outbreak of Bundibugyo virus disease: a collaborative analytical validation study.
Journal: The Lancet. Infectious diseases
Published: July 13, 2026
Replication and compartmentalization of Dobrava-Belgrade virus in the central nervous system.
Journal: Emerging microbes & infections
Published: May 29, 2026
An interferon-gamma release assay for monitoring of T-cell responses to Epstein-Barr virus: Application to multiple sclerosis.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Published: May 05, 2026
Presence but low detection rate of rat hepatitis E virus in patients in Germany 2022-2024.
Journal: Journal of hepatology
Published: April 10, 2025
Antigenic cartography using variant-specific hamster sera reveals substantial antigenic variation among Omicron subvariants.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 30, 2024
Humoral immune escape by current SARS-CoV-2 variants BA.2.86 and JN.1, December 2023.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: January 12, 2024
Divergent Genotype of Hepatitis A Virus in Alpacas, Bolivia, 2019.
Journal: Emerging infectious diseases
Published: October 05, 2023
Humoral immune responses remain quantitatively impaired but improve qualitatively in anti-CD20-treated patients with multiple sclerosis after three or four COVID-19 vaccinations.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: March 28, 2023
90K/LGALS3BP expression is upregulated in COVID-19 but may not restrict SARS-CoV-2 infection.
Journal: Clinical and experimental medicine
Published: January 08, 2023
Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron.
Journal: iScience
Published: August 08, 2022
SARS-CoV-2 rapid antigen test sensitivity and viral load in newly symptomatic hospital employees in Berlin, Germany, December, 2020 to February, 2022: an observational study.
Journal: The Lancet. Microbe
Published: May 09, 2022
Last Updated: 09/26/2026